Histone H3 deacetylation promotes host cell viability for efficient infection by Listeria monocytogenes

PLoS Pathog. 2021 Dec 20;17(12):e1010173. doi: 10.1371/journal.ppat.1010173. eCollection 2021 Dec.

Abstract

For many intracellular bacterial pathogens manipulating host cell survival is essential for maintaining their replicative niche, and is a common strategy used to promote infection. The bacterial pathogen Listeria monocytogenes is well known to hijack host machinery for its own benefit, such as targeting the host histone H3 for modification by SIRT2. However, by what means this modification benefits infection, as well as the molecular players involved, were unknown. Here we show that SIRT2 activity supports Listeria intracellular survival by maintaining genome integrity and host cell viability. This protective effect is dependent on H3K18 deacetylation, which safeguards the host genome by counteracting infection-induced DNA damage. Mechanistically, infection causes SIRT2 to interact with the nucleic acid binding protein TDP-43 and localise to genomic R-loops, where H3K18 deacetylation occurs. This work highlights novel functions of TDP-43 and R-loops during bacterial infection and identifies the mechanism through which L. monocytogenes co-opts SIRT2 to allow efficient infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Survival / physiology
  • Histones / metabolism*
  • Host-Pathogen Interactions / physiology*
  • Humans
  • Listeria monocytogenes / metabolism
  • Listeria monocytogenes / pathogenicity*
  • Listeriosis / metabolism*
  • Sirtuin 3 / metabolism*

Substances

  • Histones
  • Sirtuin 3

Grants and funding

MJGE is supported by a fellowship from the French Government’s Investissement d’Avenir program, the Laboratoire d’Excellence ‘‘Integrative Biology of Emerging Infectious Diseases’’ Agence Nationale de la Recherche (ANR): ANR-10-LABX-62-EIBID. Work in the M.A.H. laboratory received financial support from the Institut Pasteur, the Agence Nationale de la Recherche (ANR: https://anr.fr/):ANR-17-CE12-0007, the Fondation pour la Recherche Médicale (FRM: https://www.frm.org/): EQU202003010152, the Fondation iXCore-iXLife (https://ixlife.com/) and the Pasteur-Weizmann research fund,(https://www.weizmann-france.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.